180 related articles for article (PubMed ID: 29167217)
1. 5-FU-induced leukoencephalopathy with reversible lesion of splenium of corpus callosum in a patient with colorectal cancer.
Acharya G; Cruz Carreras MT; Rice TW
BMJ Case Rep; 2017 Nov; 2017():. PubMed ID: 29167217
[TBL] [Abstract][Full Text] [Related]
2. Leukoencephalopathy with transient splenial lesions related to 5-fluorouracil or capecitabine.
Perrain V; Bihan K; Bompaire F; Houillier C; Jomier F; Leclercq D; Combret S; Mahé J; Ricard D; Berzero G; Psimaras D
Eur J Neurol; 2021 Jul; 28(7):2396-2402. PubMed ID: 33817933
[TBL] [Abstract][Full Text] [Related]
3. Capecitabine-induced acute toxic leukoencephalopathy.
Obadia M; Leclercq D; Wasserman J; Galanaud D; Dormont D; Sahli-Amor M; Psimaras D; Pyatigorskaya N; Law-Ye B
Neurotoxicology; 2017 Sep; 62():1-5. PubMed ID: 28487252
[TBL] [Abstract][Full Text] [Related]
4. 5-FU-induced neurotoxicity in cancer patients with profound DPD deficiency syndrome: a report of two cases.
Cordier PY; Nau A; Ciccolini J; Oliver M; Mercier C; Lacarelle B; Peytel E
Cancer Chemother Pharmacol; 2011 Sep; 68(3):823-6. PubMed ID: 21553285
[TBL] [Abstract][Full Text] [Related]
5. Capecitabine induces both cardiomyopathy and multifocal cerebral leukoencephalopathy.
Endo A; Yoshida Y; Nakashima R; Takahashi N; Tanabe K
Int Heart J; 2013; 54(6):417-20. PubMed ID: 24309454
[TBL] [Abstract][Full Text] [Related]
6. [Early diagnosis of capecitabine-induced acute leukoencephalopathy by using diffusion-weighted MRI].
Shimoyama R; Ban T; Miyake K; Isogai N; Ikegaya Y; Kawachi J; Ogino H; Watanabe K
Gan To Kagaku Ryoho; 2014 Oct; 41(10):1251-3. PubMed ID: 25335709
[TBL] [Abstract][Full Text] [Related]
7. 5-FU induced acute toxic leukoencephalopathy: early recognition and reversibility on DWI-MRI.
Maheen Anwar SS; Mubarak F; Sajjad Z; Azeemuddin M
J Coll Physicians Surg Pak; 2014 Mar; 24 Suppl 1():S8-10. PubMed ID: 24718016
[TBL] [Abstract][Full Text] [Related]
8. Early detection of 5-FU-induced acute leukoencephalopathy on diffusion-weighted MRI.
Akitake R; Miyamoto S; Nakamura F; Horimatsu T; Ezoe Y; Muto M; Chiba T
Jpn J Clin Oncol; 2011 Jan; 41(1):121-4. PubMed ID: 20926409
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and management of 5-fluorouracil (5-FU)-induced acute leukoencephalopathy: lessons learnt from a single-Centre case series.
Jose N; Joel A; Selvakumar RJ; Ramireddy J; John AO; Georgy JT; Singh A; Ram TS
J Egypt Natl Canc Inst; 2022 May; 34(1):22. PubMed ID: 35599280
[TBL] [Abstract][Full Text] [Related]
10. Teaching NeuroImages: 5-FU-induced acute leukoencephalopathy.
Mehta S; Singh G; Paul BS
Neurology; 2013 Apr; 80(18):e191. PubMed ID: 23628936
[No Abstract] [Full Text] [Related]
11. [Late-onset leukoencephalopathy induced by long-term chemotherapy with capecitabine and cyclophosphamide for liver metastasis from breast cancer].
Yasaki S; Tukamoto Y; Yuasa N; Ishikawa T; Yoshii F
Rinsho Shinkeigaku; 2012; 52(4):251-6. PubMed ID: 22531658
[TBL] [Abstract][Full Text] [Related]
12. Reversible impairment of auditory callosal pathway in 5-fluorouracil-induced leukoencephalopathy: parallel changes in function and imaging.
Fujimoto C; Ito K; Iwasaki S; Nakao K; Sugasawa M
Otol Neurotol; 2006 Aug; 27(5):716-9. PubMed ID: 16691149
[TBL] [Abstract][Full Text] [Related]
13. Reversible findings of restricted diffusion in 5-fluorouracil neurotoxicity.
Lucato LT; McKinney AM; Short J; Teksam M; Truwit CL
Australas Radiol; 2006 Aug; 50(4):364-8. PubMed ID: 16884425
[TBL] [Abstract][Full Text] [Related]
14. 5-FU-induced peripheral neuropathy: a rare complication of a well-known drug.
van Laarhoven HW; Verstappen CC; Beex LV; Kappelle AC; Punt CJ
Anticancer Res; 2003; 23(1B):647-8. PubMed ID: 12680161
[TBL] [Abstract][Full Text] [Related]
15. Sex-Dependent Adverse Drug Reactions to 5-Fluorouracil in Colorectal Cancer.
Lim H; Kim SY; Lee E; Lee S; Oh S; Jung J; Kim KS; Moon A
Biol Pharm Bull; 2019; 42(4):594-600. PubMed ID: 30930418
[TBL] [Abstract][Full Text] [Related]
16. Teaching NeuroImages: Transient mutism associated with splenium lesion in capecitabine-induced leukoencephalopathy.
Nicoletti T; Spagni G; Luigetti M; Iorio R
Neurology; 2019 Feb; 92(9):e1000-e1001. PubMed ID: 30804069
[No Abstract] [Full Text] [Related]
17. Atypical diffusion-restricted lesion in 5-Fluorouracil encephalopathy.
Lee WW; Kim JS; Son KR; Kwon HM
AJNR Am J Neuroradiol; 2012 Aug; 33(7):E102-3. PubMed ID: 22403780
[TBL] [Abstract][Full Text] [Related]
18. Intermediate dose 5-fluorouracil-induced encephalopathy.
Kim YA; Chung HC; Choi HJ; Rha SY; Seong JS; Jeung HC
Jpn J Clin Oncol; 2006 Jan; 36(1):55-9. PubMed ID: 16436463
[TBL] [Abstract][Full Text] [Related]
19. Thymidylate synthase gene polymorphism predicts toxicity in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy.
Lecomte T; Ferraz JM; Zinzindohoué F; Loriot MA; Tregouet DA; Landi B; Berger A; Cugnenc PH; Jian R; Beaune P; Laurent-Puig P
Clin Cancer Res; 2004 Sep; 10(17):5880-8. PubMed ID: 15355920
[TBL] [Abstract][Full Text] [Related]
20. Putative role of dihydropyrimidine dehydrogenase in the toxic side effect of 5-fluorouracil in colorectal cancer patients.
Katona C; Kralovánszky J; Rosta A; Pandi E; Fónyad G; Tóth K; Jeney A
Oncology; 1998; 55(5):468-74. PubMed ID: 9732227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
